Globus Medical, Inc. ( GMED) - Key Metrics
GMED Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $6.11 | $1.04 | $1.84 | $1.42 |
| 2025Q3 | $5.72 | $0.88 | $1.86 | $1.63 |
| 2025Q2 | $5.51 | $1.50 | $0.58 | $0.23 |
| 2025Q1 | $4.37 | $0.55 | $1.30 | $1 |
GMED Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 20.98 |
| 2025Q3 | ? | 16.19 |
| 2025Q2 | ? | 9.83 |
| 2025Q1 | ? | 33.16 |
GMED Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.40% | ? |
| 2025Q4 | 1.63% | ? |
| 2025Q3 | 2.84% | ? |
| 2025Q2 | 0.39% | ? |
| 2025Q1 | 1.36% | ? |
GMED
Price: $80
52 week price:
Earnings Per Share: 4.28 USD
P/E Ratio: 17.66
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 237483
Ebitda: 46.6 millionMarket Capitalization: 10.5 billion